Infectious Diseases Completed Phase 4 Trials for Piperacillin (DB00319)

Also known as: Infectious Disease

IndicationStatusPhase
DBCOND0028267 (Infectious Diseases)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01198925Assessment of the Optimal Dosing of Piperacillin-tazobactam in Intensive Care Unit Patients: Extended Versus Continuous InfusionTreatment